Skip to main content

InflaRx N.V.

IFRX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001708688

No open-market purchases or sales by InflaRx N.V. insiders were filed in the last 90 days; 62 institutions reported holding it in 13F filings for Q2 2026, worth $211.6M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding InflaRx N.V. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of IFRX: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders3733−4
Shares13.8M13.2M−629.1K (−4.5%)
Value$21.3M$23.0M+$1.67M (+7.8%)

New holders (4)

Institutions that held InflaRx N.V. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to IFRX in Q2 2024
InstitutionSharesValue% of portfolio
Woodline Partners LP173,586$302.0K0.00%
Two Sigma Securities, LLC12,070$21.0K0.00%
Group One Trading, L.P.795$1.38K0.00%
JPMorgan Chase & Co58$1010.00%

Sold out (8)

Institutions that held InflaRx N.V. at the end of Q1 2024 and filed for Q2 2024 without it.

Institutions that sold out of IFRX in Q2 2024
InstitutionShares, Q1 2024Value, Q1 2024
Tang Capital Management LLC769,065$1.18M
Prelude Capital Management, LLC194,465$299.5K
Millennium Management LLC139,957$215.5K
Jane Street Group, LLC46,515$71.6K
XTX Topco Ltd23,153$35.7K
Balyasny Asset Management LLC12,534$19.3K
Engineers Gate Manager LP12,251$18.9K
Tower Research Capital LLC (TRC)8,466$13.0K